Delivery Order SPE2DR25D2003-SPE2DR26FR14E
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,983.60 to AmerisourceBergen Drug Corp for the supply of Capecitabine 500 mg tablets (120-count units) with a completion deadline of December 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Capecitabine is a chemotherapy medication used in cancer treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a $1,775.01 delivery order to AmerisourceBergen Drug Corp for Capecitabine 500 mg tablets (120-count) on April 23, 2025, with completion scheduled for April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing under a delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Capecitabine 500 mg tablets (120 count) with a ceiling value of $1,147.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $7,701.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Capecitabine 500 mg, with an ultimate completion date of November 7, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office division, with performance at the company's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, valued at $1,124.64. This is a firm fixed-price, non-set-aside contract with a completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Capecitabine 500 mg tablets (120-count units) valued at $1,628.98. This competitive delivery order, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,107.35 to AmerisourceBergen Drug Corp for 120 tablets of Capecitabine 500 mg, with a completion date of November 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single transaction within the broader federal pharmaceutical supply chain supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,647.00 to AmerisourceBergen Drug Corp for the supply of Capecitabine 500 mg tablets (120 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. As a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, with a ceiling value of $1,093.68. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract was not set aside for any particular business category and was competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency for Capecitabine 500 mg tablets (120-count units) valued at $1,009.98, with an ultimate completion date of December 4, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...